During the past decade, Discover Vision Centers conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Discover Vision Centers" #1 collaborator was "AbbVie" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Discover Vision Centers" are "Aphakia" (2 trials), "Cataract" (2 trials), "Myopia" (2 trials), "Astigmatism" (1 trials) and "Cataract Surgery" (1 trials). Many other conditions were trialed in "Discover Vision Centers" in a lesser frequency.

Most popular intervention types in "Discover Vision Centers" are "Device" (5 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Control IOL" (2 trials), "Light Adjustable lens (LAL) and Light Delivery Device (LDD)" (2 trials), "0.5% Omaveloxolone Ophthalmic Suspension" (1 trials), "1% Omaveloxolone Ophthalmic Suspension" (1 trials) and "Carl Zeiss Meditec VisuMax Femtosecond Laser" (1 trials). Other intervention names were less common.

The vast majority of trials in "Discover Vision Centers" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Discover Vision Centers". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Discover Vision Centers, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Discover Vision Centers, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".